A new study has found that aspirin use can cut the risk of breast cancer by almost 25 percent.
The study was conducted by researchers in Toronto who found that women who regularly used the medicine had "a statistically significant drop in risk of breast cancer".
Adequate Intake of Vitamin D Reduces Breast and Colon Cancer Rates
Sufficient intake of Vitamin D3 might prevent 60,000 cases of colon and breast cancer every year across the globe.
Advertisement
The researchers suggest that aspirin reduces cancer risk by blocking key enzymes crucial for the formation of cancerous tumours, reports the Mirror.
However, the researchers insist that the finding is not reason enough for women to start popping the pill, for the high doses needed to cut cancer risk may increase the risk of gastric bleeding, as drugs such as this can damage the lining of the stomach.
Dr Emma Pennery, of Breast Cancer Care, also used women not to take the drug without consulting a doctor.
"The jury is still out. These drugs can have side effects and I would not recommend healthy young women to start taking them," she said.
The study is published in the American Journal of Epidemiology
Source: ANI
LIN/J
Advertisement
Dr Emma Pennery, of Breast Cancer Care, also used women not to take the drug without consulting a doctor.
"The jury is still out. These drugs can have side effects and I would not recommend healthy young women to start taking them," she said.
The study is published in the American Journal of Epidemiology
Source: ANI
LIN/J
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.